Delivery Order SPE2DR25D3501-SPE2DR26FM2SE
- Not listed
- The Defense Logistics Agency awarded a $9,829.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract is a non-set-aside award with an ultimate completion date of January 9, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,213.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,391.88 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $13,523.28 delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ferumoxytol is an intravenous iron replacement therapy used to treat iron deficiency anemia, particularly in patients with chronic...
- AmerisourceBergen Drug Corp was awarded a delivery order on November 17, 2025, valued at $1,307.90 for the supply of Ferumoxytol 510 mg/17 ml vials. This contract is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made by the Defense Logistics Agency under a competitive process with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,720.55 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 21, 2026, with performance to be fulfilled from the awardee's location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Ferumoxytol 510 mg/17 mL vials valued at $3,451.18 with a firm fixed price structure. The award was made on December 1, 2025, with an ultimate completion date of December 2, 2025, and does not carry a set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,080.80 delivery order to AmerisourceBergen Drug Corp for 510 mg/17 mL vials of Ferumoxytol, an intravenous iron replacement therapy. The contract, awarded on October 28, 2025, with an ultimate completion date of October 29, 2025, represents a firm fixed price delivery under a non-competitive, non-set-aside arrangement. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,285.55 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract was executed on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ferumoxytol is an intravenous iron replacement therapy used to treat iron deficiency anemia, commonly utilized in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded contract, valued at $1,351.00 with a firm fixed-price structure, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order is scheduled for completion by October 29, 2025, with performance taking place at the contractor's corporate...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2SEDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,615.80 for Ferumoxytol 510 mg/17 ml vials on January 20, 2026, with completion scheduled for January 21, 2026. This is a firm fixed-price, non-set-aside award issued under a competitive procurement process. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 vehicle valued through December 2031 that serves as the primary procurement mechanism for pharmaceutical and medical supplies supporting military healthcare programs globally. Ferumoxytol is an iron-replacement therapy used in clinical settings, and this order represents routine pharmaceutical replenishment consistent with AmerisourceBergen's extensive portfolio of federal medical supply contracts covering brand-name and generic medications, specialty pharmaceuticals, and medical devices across multiple therapeutic domains for military treatment facilities and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/19/26 |